These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9537816)

  • 1. Intracellular Ca2+ elevation and contraction due to prostaglandin F2alpha in rat aorta.
    Tosun M; Paul RJ; Rapoport RM
    Eur J Pharmacol; 1997 Dec; 340(2-3):203-8. PubMed ID: 9537816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of norepinephrine-induced contraction by primary prostaglandin receptor activation in rat aorta.
    Rapoport RM
    Eur J Pharmacol; 1993 Oct; 243(2):207-10. PubMed ID: 8276071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of extracellular Ca++ influx via L-type and non-L-type Ca++ channels in thromboxane A2 receptor-mediated contraction in rat aorta.
    Tosun M; Paul RJ; Rapoport RM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):921-8. PubMed ID: 9495850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
    Pfister SL; Pratt PE; Kurian J; Campbell WB
    Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester-induced phosphoinositide hydrolysis in rat aorta: role of cyclooxygenase products.
    Rapoport RM; Williams SP; Campbell AK
    Life Sci; 2000 Sep; 67(15):1815-24. PubMed ID: 11043604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.
    Keith RA; Salama AI
    Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP; Dorn GW; Rapoport RM
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
    Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta.
    Ozaki H; Abe A; Uehigashi Y; Kinoshita M; Hori M; Mitsui-Saito M; Karaki H
    Jpn J Pharmacol; 1996 Jul; 71(3):231-7. PubMed ID: 8854205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
    Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries.
    Snetkov VA; Knock GA; Baxter L; Thomas GD; Ward JP; Aaronson PI
    J Physiol; 2006 Feb; 571(Pt 1):147-63. PubMed ID: 16357015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
    Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
    J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17 beta-Estradiol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery.
    Han SZ; Karaki H; Ouchi Y; Akishita M; Orimo H
    Circulation; 1995 May; 91(10):2619-26. PubMed ID: 7743625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity.
    Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T
    Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors.
    Okon EB; Golbabaie A; van Breemen C
    Br J Pharmacol; 2002 Oct; 137(4):545-53. PubMed ID: 12359637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
    Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
    Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.